Results 1 to 10 of about 80,904 (179)
Circulating Biomarkers in Coronary Microvascular Dysfunction
Coronary microvascular dysfunction is an underdiagnosed pathologic process that is associated with adverse clinical outcomes. Biomarkers, molecules measurable in the blood, could inform the clinician by aiding in the diagnosis and management of coronary ...
Teja Chakrala +4 more
doaj +3 more sources
Coronary Microvascular Dysfunction [PDF]
Over the past couple of decades, accumulating evidence has shown that structural and functional abnormalities of coronary microvasculature are highly prevalent, associated with adverse clinical outcomes in patients with various cardiovascular diseases. The term coronary microvascular dysfunction (CMD) has been coined to refer to this clinical condition
Shigeo Godo +4 more
+7 more sources
Coronary Microvascular Dysfunction
Thomas H. Schindler, MD, PhD +1 more
doaj +2 more sources
Coronary microvascular dysfunction [PDF]
Patients with coronary microvascular dysfunction (CMVD) represent a widespread population and despite the good prognosis, many of them have a poor quality of life with strong limitations in their daily activities because of the angina symptoms.
Sucato V. +4 more
+8 more sources
Inflammation in Coronary Microvascular Dysfunction [PDF]
Chronic low-grade inflammation is involved in coronary atherosclerosis, presenting multiple clinical manifestations ranging from asymptomatic to stable angina, acute coronary syndrome, heart failure and sudden cardiac death. Coronary microvasculature consists of vessels with a diameter less than 500 μm, whose potential structural and functional ...
Marios Sagris +7 more
openaire +3 more sources
Coronary Microvascular Dysfunction [PDF]
The link between myocardial ischemia and obstructive atherosclerosis is established beyond any doubt and coronary angiography has demonstrated a relationship between the severity and extent of coronary artery disease (CAD) and survival. In the past two decades, however, a number of clinical studies have highlighted the potential role of coronary ...
CAMICI , PAOLO, Crea F.
+6 more sources
Coronary Microvascular Dysfunction
Coronary microvascular dysfunction (CMD) is a key mechanism underlying ischemic heart disease (IHD), yet its diagnosis and treatment remain challenging. This article presents a comprehensive overview of CMD research, covering its pathogenesis, diagnostic criteria, assessment techniques, risk factors, and therapeutic strategies.
Yader Sandoval +33 more
+9 more sources
Coronary Microvascular Dysfunction: Epidemiology, Clinical Presentation, Diagnosis and Treatment
In a significant number of patients with symptoms of angina pectoris or myocardial infarction with ischemic changes in the myocardium, according to the results of instrumental research methods, there is no hemodynamically significant stenosis of the ...
E. L. Trisvetova
doaj +1 more source
INOCA/ANOCA: Mechanisms and novel treatments
Angina or ischemia with no obstructive coronary disease (ANOCA/INOCA) is a common but under-treated condition due to poorly understood pathophysiologic mechanisms, limited diagnostic tools, and lack of proven targeted therapy.
Namrita D. Ashokprabhu +3 more
doaj +1 more source
Role of coronary microvascular dysfunction in heart failure with preserved ejection fraction [PDF]
Heart failure with preserved ejection fraction (HFpEF) is one of the greatest unmet needs in modern medicine. The lack of an appropriate therapy may reflect the lack of an accurate comprehension of its pathophysiology.
Francesco Tona +3 more
doaj +1 more source

